• Analysis of phosphorylated peptides using a bioinert YMC-Accura Triart C18 column
    Figure 1: Synthetic phosphorylated peptides used in this application.
  • Figure 2: Extracted ion chromatograms (EICs) of phosphopeptide mixture separated with the bioinert YMC-Accura Triart C18 column and the stainless steel column hardware equilibrated with 10 injections.
  • Figure 3: Peak areas of the four phosphorylated peptides after 1-10 injections using the bioinert YMC-Accura Triart C18 column (blue) and the stainless steel standard column (grey).

Columns (LC)

Analysis of phosphorylated peptides using a bioinert YMC-Accura Triart C18 column

This application note demonstrates the benefit of specifically designed column hardware for biomolecules, which contain phosphate group(s). This includes: (phospho-)peptides, nucleotides and oligonucleotides.

The recently introduced YMC-Accura column hardware has been designed to eliminate any interaction between sample and stainless steel due to a strict coating of column body and frit. It allows sharp peaks, stable recoveries and eliminates consequential carry-over effects. This makes it a great choice for working at trace-levels.

As an example, this application note shows results obtained with standard column hardware in comparison with the bioinert coated YMC-Accura Triart C18 column. To demonstrate the beneficial effect four phosphorylated peptides (figure 1) have been selected. To eliminate the influence of any potential interaction between these critical analytes and any metal parts in the LC system, all measurements were performed using a fully bioinert LC system.

Figure 2 shows that use of the bioinert YMC-Accura Triart C18 column led to higher intensities and peak areas for all peaks. Additionally, the high recovery rate from the YMC-Accura Triart C18 column also enabled the detection of the challenging phosphopeptide T43pp, which contains two phosphate residues. In contrast, the analysis with the standard column hardware showed no signal, even after thorough equilibration after several sample injections.

The bioinert YMC-Accura Triart C18 column provided very stable peak areas. The deviation within the first 10 injections was about 6–9% for T18p, T19p and T43p. Only T43pp saturated after 10 injections with about 32% increase in peak area (figure 3). This proves that little or no column conditioning is necessary with the YMC-Accura Triart C18 column. Further, the column showed very reproducible peak performance. Almost no peak tailing could be observed.

These results demonstrate that the bioinert hardware is an essential tool for the analysis of biomolecules. In this case, all peptides were detected with much higher recovery rate than with the standard column hardware. Even challenging peptides can be analysed reproducibly. The use of bioinert YMC-Accura Triart columns has several benefits: higher recovery, better peak shapes, greater reproducibility as well as little or no conditioning required. This makes YMC-Accura Triart columns an excellent choice for the analysis of critical biomolecules such as phosphopeptides.


Events

SCM-11

Jan 20 2025 Amsterdam, Netherlands

Medlab Middle East

Feb 03 2025 Dubai, UAE

China Lab 2025

Feb 05 2025 Guangzhou, China

PITTCON 2025

Mar 01 2025 Boston, MA, USA

H2 Forum

Mar 04 2025 Berlin, Germany

View all events